Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taher Al-Tweigeri

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
BMC Cancer|December 7, 2007
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experienceNaser Elkum, Said Dermime, Dahish Ajarim, et al.
Cancer Research|April 17, 2008
Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changesNahed M Hawsawi, Hazem Ghebeh, Siti-Faujiah Hendrayani, et al.
Breast Cancer Research : BCR|May 17, 2020
Clinical and functional significance of tumor/stromal ATR expression in breast cancer patientsMysoon M Al-Ansari, Maher Al-Saif, Maria Arafah, et al.
Antibodies (Basel, Switzerland)|July 2, 2021
Higher PD-L1 Immunohistochemical Detection Signal in Frozen Compared to Matched Paraffin-Embedded Formalin-Fixed TissuesHazem Ghebeh, Fatmah A Mansour, Dilek Colak, et al.
Cell Death Discovery|September 9, 2025
A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort studySyed S Islam, Taher Al-Tweigeri, Asma Tulbah, et al.
Breast Cancer Research : BCR|July 12, 2022
High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patientsTaher Al-Tweigeri, Noura N AlRaouji, Asma Tulbah, et al.
Oncology Letters|August 7, 2012
TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distributionAbeer J Al-Qasem, Mohamed Toulimat, Abdelmoneim M Eldali, et al.
BMC Cancer|November 19, 2014
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free femalesNisreen Al-Moghrabi, Asmaa Nofel, Nujoud Al-Yousef, et al.
Breast Cancer Research : BCR|July 15, 2010
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic moleculeHazem Ghebeh, Cynthia Lehe, Eman Barhoush, et al.
Journal of Oncology|February 25, 2021
Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast CancerTaher Al-Tweigeri, Mahmoud Elshenawy, Ahmed Badran, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
BMC Cancer|December 7, 2007
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experienceNaser Elkum, Said Dermime, Dahish Ajarim, et al.
Cancer Research|April 17, 2008
Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changesNahed M Hawsawi, Hazem Ghebeh, Siti-Faujiah Hendrayani, et al.
Breast Cancer Research : BCR|May 17, 2020
Clinical and functional significance of tumor/stromal ATR expression in breast cancer patientsMysoon M Al-Ansari, Maher Al-Saif, Maria Arafah, et al.
Antibodies (Basel, Switzerland)|July 2, 2021
Higher PD-L1 Immunohistochemical Detection Signal in Frozen Compared to Matched Paraffin-Embedded Formalin-Fixed TissuesHazem Ghebeh, Fatmah A Mansour, Dilek Colak, et al.
Cell Death Discovery|September 9, 2025
A long noncoding RNA-based serum signature predicts ado-trastuzumab emtansine (T-DM1) treatment benefit in HER2+ metastatic breast cancer patients: a multicenter cohort studySyed S Islam, Taher Al-Tweigeri, Asma Tulbah, et al.
Breast Cancer Research : BCR|July 12, 2022
High AUF1 level in stromal fibroblasts promotes carcinogenesis and chemoresistance and predicts unfavorable prognosis among locally advanced breast cancer patientsTaher Al-Tweigeri, Noura N AlRaouji, Asma Tulbah, et al.
Oncology Letters|August 7, 2012
TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distributionAbeer J Al-Qasem, Mohamed Toulimat, Abdelmoneim M Eldali, et al.
BMC Cancer|November 19, 2014
The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free femalesNisreen Al-Moghrabi, Asmaa Nofel, Nujoud Al-Yousef, et al.
Breast Cancer Research : BCR|July 15, 2010
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic moleculeHazem Ghebeh, Cynthia Lehe, Eman Barhoush, et al.
Journal of Oncology|February 25, 2021
Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast CancerTaher Al-Tweigeri, Mahmoud Elshenawy, Ahmed Badran, et al.
Pageof 5